Wall Street Is Watching Cadrenal Therapeutics (CVKD)’s Next Move
Cadrenal Therapeutics Inc. (NASDAQ:CVKD) is a biopharmaceutical company dedicated to developing transformative therapeutics that address the significant limitations…
Why I-Mab (IMAB) Could Be the Next Big Breakout in Global Biotech
I-Mab Sponsored ADR (NASDAQ:IMAB) is a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of…
ReShape Lifesciences (RSLS) & Vyome Merger Could Create a Healthcare Powerhouse
ReShape Lifesciences Inc. (NASDAQ:RSLS) is a premier medical device company dedicated to transforming the treatment of obesity and…
Trinity Biotech (TRIB) Could Be the Next Billion-Dollar Healthcare Innovator
Trinity Biotech plc (NASDAQ:TRIB) is a commercial-stage biotechnology company that has built its reputation on delivering innovative diagnostic…
Vor Biopharma (VOR) Could Be the Most Undervalued Biotech of the Year
Vor Biopharma Inc. (NASDAQ:VOR) is a clinical-stage cell and genome engineering company dedicated to pioneering novel treatments for…
180 Life Sciences (ATNF) Just Raised $425 Million—And It’s Not Just a Biotech Anymore
180 Life Sciences Corp. (NASDAQ:ATNF) is an emerging and unconventional player in the public markets, combining the high-stakes…
Editas Medicine (EDIT)’s $178 Million War Chest: The CRISPR Comeback Investors Can’t Ignore
Editas Medicine Inc. (NASDAQ:EDIT) is a pioneering gene editing company dedicated to translating the revolutionary potential of CRISPR/Cas12a…
Generation Bio (GBIO)’s $100MCash Lifeline: Is a Massive Comeback on the Horizon?
Generation Bio Co. (NASDAQ:GBIO) is a pioneering biotechnology company dedicated to transforming the treatment of genetic diseases through…
Titan Pharma (TTNP): This Tiny Drugmaker Is Taking on Big Pharma — And Could Win!
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) is a specialty pharmaceutical company dedicated to developing innovative therapeutics that address chronic medical…
Health In Tech (HIT) is Making Healthcare Affordable and Scalable for Businesses
Health In Tech Inc. (NASDAQ:HIT) is an innovative Insurtech platform that is reshaping the healthcare benefits landscape for…
Here’s Why Wall Street Is Suddenly Obsessed with ImmunityBio (IBRX)
ImmunityBio, Inc. (NASDAQ:IBRX) is a vertically integrated, commercial-stage biotechnology company dedicated to developing next-generation therapies that harness and…
BioXcel (BTAI)’s BXCL501 Could Be the Game Changer in Treating Agitation Disorders
BioXcel Therapeutics Inc. (NASDAQ:BTAI) is an innovative biopharmaceutical company leveraging cutting-edge artificial intelligence (AI) to discover and develop…
The Future of Gene Therapy is Here with Solid Biosciences (SLDB): A Look at SGT-003
Solid Biosciences Inc. (NASDAQ:SLDB) is a pioneering biotechnology company at the forefront of developing innovative gene therapies aimed…
Can Sol-Gel Technologies (SLGL) Become the Next Big Name in Dermatology?
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) is a clinical-stage biotechnology company focused on the development of innovative dermatological treatments aimed…
Assembly Bio (ASMB): The Future of Chronic Viral Disease Treatment is Here!
Assembly Biosciences, Inc. (NASDAQ:ASMB) is a leading biotechnology company dedicated to developing innovative therapies for the treatment of…
Here’s Why Verastem (VSTM) Is the Next Big Thing in Oncology
Verastem Inc. (NASDAQ:VSTM) is a clinical-stage biopharmaceutical company focused on developing and commercializing targeted therapies for cancers driven…
Kura Oncology (KURA)’s Targeted Therapies Could Dominate the Market
Kura Oncology Inc. (NASDAQ:KURA) is a clinical-stage biopharmaceutical company dedicated to the development of precision medicines for the…
AVITA Medical (RCEL) is Delivering Big Returns for Early Investors—Here’s Why You Should Buy This Now!
AVITA Medical Inc. (NASDAQ:RCEL) is a leading therapeutic company focused on acute wound care, delivering transformative solutions designed…